Thiogenesis Therapeutics clinical trials we track

Check company identity source

Phase 2 2 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
A Study to Assess TTI-0102 vs Placebo in MELAS Patients

NCT06644534 · Thiogenesis Therapeutics, Inc.

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 12 participants (planned). After: 9 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 30 Apr 2026. After: 12 Jan 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source